NSE: SUDARSCHEM | BSE: 506655

Expensive Performer

Download real time

1079.70 53.30 (5.19%)

58.78% Gain from 52W Low

62,516 NSE+BSE Volume

NSE 12 May, 2025 11:11 AM (IST)

8,483.5

Market Cap

Market Leader

1.0

Beta 1Year

Average volatility

Sudarshan Chemical Industries Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SUDARSCHEM, BSE:506655 Sudarshan Chemical Industries Ltd.

Sudarshan Chemical Industries Ltd.

31 Jan 2021

1079.70

5.19%

Sudarshan Chemical

Buy: Sudarshan Chemical Industr...

Target

ICICI Securities Limited

The company's operations and demand from end users are reverting back to normal as the economy opens up. The company's H2 is also likely to benefit amid some pent-up demand. Owing to strong demand, the company is trying to expedite its growth capex plans of | 585 crore (which have been bit delayed amid Covid), which gives strong visibility and management commitment towards future growth. Sudarshan's strong track record, with favourable macro factors and strong domestic demand are key catalysts for it. Margins are also likely to improve due to backward integration and change...

Sudarshan Chemical Industries Ltd. has gained 50.07% in the last 1 Year

Sudarshan Chemical Industries Ltd.

28 Dec 2020

1079.70

5.19%

Light House - A Quick Perspective - Sudarshan Chemical Industries Ltd.- 28 December 2020

Accumulate: Sudarshan Chemical Industr...

Way2Wealth

Incorporated in 1952, Sudarshan chemicals established itself as largest pigment producer in India (~35% market share) and the fourth-largest producer in the world. At the beginning it manufactured only inorganic pigments however gradually, expanded its product basket to organic, inorganic and effect pigments, which cover classical azo pigments, specialized azo pigments, high-performance pigments, pearlescent pigments, pthalos and pigment dispersions. Company's products offered under the brands - Sudaperm, Sudafast, Sudacolor, Sumica and Sumicos are sold to...

Sudarshan Chemical Industries Ltd. has gained 50.07% in the last 1 Year

Sudarshan Chemical Industries Ltd.

11 Dec 2020, 12:00AM

1079.70

5.19%

Sudarshan Chemical Industries Ltd

Buy: Sudarshan Chemical Industr...

Rudra Shares and Stock Brokers Ltd

Operating revenue in coming years is expected to show a marginal growth despite impact of pandemic, owing to healthy demand recovery seen from August onwards aided by higher exports as well as buoyant domestic demand. Q2 FY21 domestic business is up 70% as compared to Q1 FY21 which is reflective of the broader economy in India now coming back to normal. Further, company seeing good traction across the portfolio with coating, plastics and inks particularly doing well. Besides, global market position is expected to improve further...

Sudarshan Chemical Industries Ltd. has gained 50.07% in the last 1 Year

Sudarshan Chemical Industries Ltd.

28 Oct 2020

1079.70

5.19%

Sudarshan Chem

Buy: Sudarshan Chemical Industr...

Sharekhan

Sudarshan Chemical Industries Limited (SCIL) reported better-than-expected recovery in revenue at Rs. 429 crore (up 1% y-o-y versus our expectation of 4.9% y-o-y drop), led by better performance in the domestic business. EBITDA margin was in-line at 15.4% (up 75 bps y-o-y). Strong recovery was seen in August-September in the domestic business (up 70% q-o-q) across...

Sudarshan Chemical Industries Ltd. is trading above all available SMAs

Sudarshan Chemical Industries Ltd.

27 Oct 2020

1079.70

5.19%

Sudarshan Chemical

Buy: Sudarshan Chemical Industr...

ICICI Securities Limited

Q2 results were better than I-direct estimates on all fronts. The company's operations and demand from end users are reverting to normal as the economy opens up. Despite a challenging year, Sudarshan has reiterated its growth capex plan of | 585 crore (though delayed amid Covid), which shows its strong visibility and commitment towards future growth. Its strong track record, with favourable macro factors and strong domestic demand are key catalysts for it. Margins are also likely to improve due to backward integration, change in product mix towards margin accretive products. We...

Sudarshan Chemical I.. has an average target of 1002.00 from 2 brokers.

Sudarshan Chemical Industries Ltd.

09 Oct 2020

1079.70

5.19%

Sudarshan Chemical

Buy: Sudarshan Chemical Industr...

ICICI Securities Limited

Sudarshan Chemical Industries Ltd. is trading above all available SMAs

Sudarshan Chemical Industries Ltd.

30 Sep 2020

1079.70

5.19%

Sudarshan Chem

Buy: Sudarshan Chemical Industr...

Anand Rathi

Sudarshan Chemical I.. has an average target of 1002.00 from 2 brokers.

Sudarshan Chemical Industries Ltd.

28 Aug 2018

1079.70

5.19%

Sudarshan Chemical Industries Ltd | Q1FY19 Result Update

Results Update: Sudarshan Chemical Industr...

Edelweiss

Sudarshan Chemical Industries Ltd. (Sudarshan) reported volume growth of 10% in Q1FY19 while registering an overall revenue growth of 14%.

Sudarshan Chemical Industries Ltd. has gained 50.07% in the last 1 Year

Sudarshan Chemical Industries Ltd.

28 May 2018

1079.70

5.19%

Sudarshan Chemical Industries Ltd.| Q4FY18 Result Update

Hold: Sudarshan Chemical Industr...

Recommendation

Edelweiss

Sudarshan Chemical Industries Ltd. (Sudarshan) reported standalone Q4FY18 sales of INR 384 cr (INR 405 cr inclusive of discontinued operations of agrochemicals and its subsidiary Prescient Colors Ltd.

Sudarshan Chemical Industries Ltd. is trading above all available SMAs

Sudarshan Chemical Industries Ltd.

12 Feb 2018, 12:00AM

1079.70

5.19%

Sudarshan Chemical Industries Limited - Result Update Q3FY18

Buy: Sudarshan Chemical Industr...

Target

Edelweiss

Sudarshan Chemical Industries Limited (Sudarshan) Q3FY18: Sudarshan reported results above our estimates with robust sales pigment growth in both the domestic and export markets while margins...

Sudarshan Chemical I.. has an average target of 1002.00 from 2 brokers.

Is Sudarshan Chemical Industries Ltd. worth buying?

180 Votes:

Buy 82.78%

Sell 11.11%

Hold 6.11%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Sell SEE REPORTS >

pdf